Related Experiment Video
Updated: Jul 27, 2026

A 1.5 Hour Procedure for Identification of Enterococcus Species Directly from Blood Cultures
Published on: February 10, 2011
Attributable mortality of vancomycin resistance in ampicillin-resistant Enterococcus faecium bacteremia in Denmark
Wouter C Rottier1, Mette Pinholt2,3, Akke K van der Bij4
1Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Objective:
To study whether replacement of nosocomial ampicillin-resistant Enterococcus faecium (ARE) clones by vancomycin-resistant E. faecium (VRE), belonging to the same genetic lineages, increases mortality in patients with E. faecium bacteremia, and to evaluate whether any such increase is mediated by a delay in appropriate antibiotic therapy.
Design:
Retrospective, matched-cohort study.
Setting:
The study included 20 Dutch and Danish hospitals from 2009 to 2014.
Patients:
Within the study period, 63 patients with VRE bacteremia (36 Dutch and 27 Danish) were identified and subsequently matched to 234 patients with ARE bacteremia (130 Dutch and 104 Danish) for hospital, ward, length of hospital stay prior to bacteremia, and age. For all patients, 30-day mortality after bacteremia onset was assessed.
Methods:
The risk ratio (RR) reflecting the impact of vancomycin resistance on 30-day mortality was estimated using Cox regression with further analytic control for confounding factors.
Results:
The 30-day mortality rates were 27% and 38% for ARE in the Netherlands and Denmark, respectively, and the 30-day mortality rates were 33% and 48% for VRE in these respective countries. The adjusted RR for 30-day mortality for VRE was 1.54 (95% confidence interval, 1.06-2.25). Although appropriate antibiotic therapy was initiated later for VRE than for ARE bacteremia, further analysis did not reveal mediation of the increased mortality risk.
Conclusions:
Compared to ARE bacteremia, VRE bacteremia was associated with higher 30-day mortality. One explanation for this association would be increased virulence of VRE, although both phenotypes belong to the same well-characterized core genomic lineage. Alternatively, it may be the result of unmeasured confounding.
Insights
Vancomycin-resistant Enterococcus faecium (VRE) bacteremia is linked to increased mortality compared to ampicillin-resistant Enterococcus faecium (ARE) bacteremia. This higher mortality risk was not explained by delayed antibiotic treatment.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Epidemiology
Background:
- Nosocomial Enterococcus faecium bacteremia is a significant healthcare concern.
- The emergence of vancomycin-resistant Enterococcus faecium (VRE) poses a therapeutic challenge.
- Understanding the impact of VRE on patient mortality is crucial for guiding clinical practice.
Purpose of the Study:
- To determine if vancomycin-resistant Enterococcus faecium (VRE) bacteremia increases mortality compared to ampicillin-resistant Enterococcus faecium (ARE) bacteremia.
- To investigate whether delayed antibiotic therapy mediates any increased mortality associated with VRE.
- To analyze the impact of VRE on 30-day mortality in patients with Enterococcus faecium bacteremia.
Main Methods:
- Retrospective, matched-cohort study design.
- Inclusion of patients from 20 Dutch and Danish hospitals (2009-2014).
- Matching VRE bacteremia cases with ARE bacteremia controls based on hospital, ward, prior hospital stay, and age.
- Cox regression analysis to estimate the risk ratio for 30-day mortality.
Main Results:
- The 30-day mortality rates for ARE bacteremia were 27% (Netherlands) and 38% (Denmark).
- The 30-day mortality rates for VRE bacteremia were 33% (Netherlands) and 48% (Denmark).
- VRE bacteremia was associated with a 1.54-fold increased risk of 30-day mortality (adjusted RR, 1.06-2.25).
- Appropriate antibiotic therapy was initiated later for VRE than ARE, but this did not mediate the increased mortality.
Conclusions:
- Vancomycin-resistant Enterococcus faecium (VRE) bacteremia is associated with higher 30-day mortality compared to ampicillin-resistant Enterococcus faecium (ARE) bacteremia.
- The increased mortality risk associated with VRE may be due to increased intrinsic virulence or unmeasured confounding factors.
- Delayed antibiotic therapy does not appear to mediate the increased mortality observed in VRE infections.
More Related Videos
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance